Budget 2025: Tax cuts, sops on Pharma Inc's wish list

Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax exemptions on life-saving drugs in the upcoming Union budget. They want more oncology drugs to be tax-exempt and lower customs duties on essential medical equipment. Executives also propose incentives for AI research and standardization of GST rates on medical devices.